A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)- β-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine

Robert A. Smith, Kathryn M. Remington, Bradley D. Preston, Raymond F. Schinazi, Thomas W. North

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Mutants of feline immunodeficiency virus (FIV) resistant to (-)-β- 2',3'-dideoxy-3'-thiacytidine (3TC) were selected by culturing virus in the presence of increasing stepwise concentrations of 3TC. Two plaque-purified variants were isolated from the original mutant population, and both of these mutants were resistant to 3TC. Surprisingly, these mutants were also phenotypically resistant to 3'-azido-3'-deoxythymidine (AZT) and to the combination of 3TC and AZT. Purified reverse transcriptase (RT) from one of these plaque-purified mutants was resistant to the 5'-triphosphates of 3TC and AZT. DNA sequence analysis of the RT-encoding region of the pol gene amplified from the plaque-purified mutants revealed a Pro-to-Ser mutation at position 156 of RT. A site-directed mutant of FTV engineered to contain this Pro-156-Ser mutation was resistant to 3TC, AZT, and the combination of 3TC and AZT, confirming the role of the Pro-156-Ser mutation in the resistance of FIV to these two nucleoside analogs. This represents the first report of a lentiviral mutant resistant to the combination of AZT and 3TC due to a single, unique point mutation.

Original languageEnglish (US)
Pages (from-to)2335-2340
Number of pages6
JournalJournal of Virology
Volume72
Issue number3
StatePublished - Mar 1998

Fingerprint

Feline Immunodeficiency Virus
Feline immunodeficiency virus
Lamivudine
Zidovudine
RNA-directed DNA polymerase
RNA-Directed DNA Polymerase
point mutation
Point Mutation
mutants
Mutation
pol Genes
DNA Sequence Analysis
Nucleosides
mutation
Viruses
Population
nucleosides
sequence analysis
nucleotide sequences
viruses

ASJC Scopus subject areas

  • Immunology

Cite this

A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)- β-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine. / Smith, Robert A.; Remington, Kathryn M.; Preston, Bradley D.; Schinazi, Raymond F.; North, Thomas W.

In: Journal of Virology, Vol. 72, No. 3, 03.1998, p. 2335-2340.

Research output: Contribution to journalArticle

Smith, Robert A. ; Remington, Kathryn M. ; Preston, Bradley D. ; Schinazi, Raymond F. ; North, Thomas W. / A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)- β-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine. In: Journal of Virology. 1998 ; Vol. 72, No. 3. pp. 2335-2340.
@article{4018c1b5788a46309318fcab4e1ca8fe,
title = "A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)- β-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine",
abstract = "Mutants of feline immunodeficiency virus (FIV) resistant to (-)-β- 2',3'-dideoxy-3'-thiacytidine (3TC) were selected by culturing virus in the presence of increasing stepwise concentrations of 3TC. Two plaque-purified variants were isolated from the original mutant population, and both of these mutants were resistant to 3TC. Surprisingly, these mutants were also phenotypically resistant to 3'-azido-3'-deoxythymidine (AZT) and to the combination of 3TC and AZT. Purified reverse transcriptase (RT) from one of these plaque-purified mutants was resistant to the 5'-triphosphates of 3TC and AZT. DNA sequence analysis of the RT-encoding region of the pol gene amplified from the plaque-purified mutants revealed a Pro-to-Ser mutation at position 156 of RT. A site-directed mutant of FTV engineered to contain this Pro-156-Ser mutation was resistant to 3TC, AZT, and the combination of 3TC and AZT, confirming the role of the Pro-156-Ser mutation in the resistance of FIV to these two nucleoside analogs. This represents the first report of a lentiviral mutant resistant to the combination of AZT and 3TC due to a single, unique point mutation.",
author = "Smith, {Robert A.} and Remington, {Kathryn M.} and Preston, {Bradley D.} and Schinazi, {Raymond F.} and North, {Thomas W.}",
year = "1998",
month = "3",
language = "English (US)",
volume = "72",
pages = "2335--2340",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)- β-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine

AU - Smith, Robert A.

AU - Remington, Kathryn M.

AU - Preston, Bradley D.

AU - Schinazi, Raymond F.

AU - North, Thomas W.

PY - 1998/3

Y1 - 1998/3

N2 - Mutants of feline immunodeficiency virus (FIV) resistant to (-)-β- 2',3'-dideoxy-3'-thiacytidine (3TC) were selected by culturing virus in the presence of increasing stepwise concentrations of 3TC. Two plaque-purified variants were isolated from the original mutant population, and both of these mutants were resistant to 3TC. Surprisingly, these mutants were also phenotypically resistant to 3'-azido-3'-deoxythymidine (AZT) and to the combination of 3TC and AZT. Purified reverse transcriptase (RT) from one of these plaque-purified mutants was resistant to the 5'-triphosphates of 3TC and AZT. DNA sequence analysis of the RT-encoding region of the pol gene amplified from the plaque-purified mutants revealed a Pro-to-Ser mutation at position 156 of RT. A site-directed mutant of FTV engineered to contain this Pro-156-Ser mutation was resistant to 3TC, AZT, and the combination of 3TC and AZT, confirming the role of the Pro-156-Ser mutation in the resistance of FIV to these two nucleoside analogs. This represents the first report of a lentiviral mutant resistant to the combination of AZT and 3TC due to a single, unique point mutation.

AB - Mutants of feline immunodeficiency virus (FIV) resistant to (-)-β- 2',3'-dideoxy-3'-thiacytidine (3TC) were selected by culturing virus in the presence of increasing stepwise concentrations of 3TC. Two plaque-purified variants were isolated from the original mutant population, and both of these mutants were resistant to 3TC. Surprisingly, these mutants were also phenotypically resistant to 3'-azido-3'-deoxythymidine (AZT) and to the combination of 3TC and AZT. Purified reverse transcriptase (RT) from one of these plaque-purified mutants was resistant to the 5'-triphosphates of 3TC and AZT. DNA sequence analysis of the RT-encoding region of the pol gene amplified from the plaque-purified mutants revealed a Pro-to-Ser mutation at position 156 of RT. A site-directed mutant of FTV engineered to contain this Pro-156-Ser mutation was resistant to 3TC, AZT, and the combination of 3TC and AZT, confirming the role of the Pro-156-Ser mutation in the resistance of FIV to these two nucleoside analogs. This represents the first report of a lentiviral mutant resistant to the combination of AZT and 3TC due to a single, unique point mutation.

UR - http://www.scopus.com/inward/record.url?scp=0031911770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031911770&partnerID=8YFLogxK

M3 - Article

VL - 72

SP - 2335

EP - 2340

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 3

ER -